Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder

NCT: NCT07112105 · NOT_YET_RECRUITING

NCT IDNCT07112105
StatusNOT_YET_RECRUITING
Start Date2026-05-01
Completion2029-12-31

Brief Summary

The purpose of this study is to establish a new treatment (repetitive transcranial stimulation (rTMS)) for Veterans with stimulant use disorder (SUD). Despite the large public health burden imposed by SUD, there is currently no FDA-approved or widely recognized effective somatic treatment. This placebo controlled study will test the effectiveness of rTMS in the treatment of SUD, and explore biomarkers that may guide patient selection for rTMS treatment and predict treatment response.

Frequently Asked Questions

What is Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder?

Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder is a clinical trial registered under NCT07112105. Current status: NOT_YET_RECRUITING.

What is the status of NCT07112105?

The current status of NCT07112105 (Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder) is: NOT_YET_RECRUITING.

When did Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder start?

Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder started on 2026-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑